source
- Abridge secures strategic investment from Eli Lilly and partners with Nvidia on AI foundation modelAbridge, a health‑tech AI company, announced two new deals on Thursday in New York. Eli Lilly will make a strategic investment in Abridge, signaling pharma interest in AI scribes that document vis…
- Some U.S. Employers Plan to End GLP-1 Obesity Drug Coverage in 2027, Even as Prices FallA Reuters report says roughly 10% of U.S. employers that currently cover GLP-1 medicines for weight loss intend to stop covering them in 2027. The move comes as enrollment in obesity-treating drugs…